Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0476 in seasonal allergic rhinitis
NCT00446186Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2004
- Primary completion
- Mar 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of montelukast in seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Feb 2004; status: completed.
02
Drugs
montelukast
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00446186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446186.